Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Ionis Pharmaceuticals: Q4 Earnings Snapshot
Ionis Pharmaceuticals: Q4 Earnings Snapshot
Associated Press Finance
Wed, February 25, 2026 at 9:12 PM GMT+9 1 min read
In this article:
IONS
+1.00%
CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $229 million in its fourth quarter.
On a per-share basis, the Carlsbad, California-based company said it had a loss of $1.41. Losses, adjusted for stock option expense, came to $1.14 per share.
The drug discovery and development company posted revenue of $203 million in the period, surpassing Street forecasts. Seven analysts surveyed by Zacks expected $155.6 million.
For the year, the company reported a loss of $381 million, or $2.38 per share. Revenue was reported as $944 million.
Ionis Pharmaceuticals expects full-year revenue in the range of $800 million to $825 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on IONS at
Terms and Privacy Policy
Privacy Dashboard
More Info